Adult patients with breast cancer are a prespecified subgroup of the recently conducted OnTarget trial evaluating crofelemer for prophylaxis of CTD
Read More
This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations work to ensure that any and all information contained within is true and accurate as of the date hereof to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.
Read More
Makor Resources and AUYAN secure funding from Innovate UK, the UK Government's National Innovation Agency, to develop a remote sensing solution that leverages space technology to de-risk investments and address sustainability challenges across Africa
Read More
A lawsuit was filed for certain investors in DMC Global Inc. (NASDAQ: BOOM) shares. Investors who purchased more than $100,000 in shares of DMC Global Inc. (NASDAQ: BOOM) between May and November 2024 have certain options and there are short and strict deadlines running. Deadline: February 04, 2025. Those DMC Global Inc. (NASDAQ: BOOM investors should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554
Read More
Minister of Tourism to Officiate Ribbon-Cutting & Special Announcements in NYC's Times Square (B'way & 45th) TODAY, December 8th at 4:00PM
Colorful Costumes, Authentically Caribbean Dome Experience, Food Tastings, Cigar-Making
MEDIA ADVISORY
FOR IMMEDIATE RELEASE
Today, Sunday, December 8, 2024
914-420-8219
Renovate.com, a home improvement platform, is transforming the renovation experience by providing a solution for homeowners to connect with reliable contractors and secure pre-qualification for financing all in one place.
Read More
Grant will support The Center by Lendistry's "Main Street Goes Green" initiative, equipping underserved entrepreneurs with tools to thrive in a greener economy.
Read MoreMilrose Consultants, a leading national provider of building code compliance, fulfillment, and consulting solutions, is pleased to announce the acquisition of Construction Specifications, Inc (CSI), a New Jersey-based firm specializing in architectural specification writing and consulting.
Read MoreThe study is one of five clinical efforts - three IIT proof-of-concept studies and two Phase 2 studies - of crofelemer for the rare disease indications of SBS-IF and/or microvillus inclusion disease (MVID), an ultrarare congenital diarrheal disorder, in the US, EU, and/or Middle East/North Africa (MENA) regions; availability of IIT proof-of-concept results potentially in Q2 2025
Crofelemer, Jaguar's novel plant-based prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both SBS-IF and MVID
Read More
Highlights:
560% Year over Year revenue growth. Reporting $4.35 million annual revenue.
Deployed proprietary AI-powered technology platform PRISIM+ - Predictive Route Inventory + Service Management - designed to optimize GPOX operations.
Expanded DSD distribution in three service areas with three new distribution Mini-Hubs
Expanded retail network adding TXB Stores - Texas Born - convenience stores with 52 locations.